Invesco’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.88B | Buy |
3,349,677
+53,500
| +2% | +$34.3M | 0.18% | 90 |
|
|
2025
Q4 | $2.23B | Buy |
3,296,177
+1,975,914
| +150% | +$1.35B | 0.21% | 75 |
|
|
2025
Q3 | $844M | Buy |
1,320,263
+161,782
| +14% | +$98.2M | 0.13% | 154 |
|
|
2025
Q2 | $621M | Sell |
1,158,481
-7,925
| -0.7% | -$3.79M | 0.11% | 222 |
|
|
2025
Q1 | $490M | Buy |
1,166,406
+5,418
| +0.5% | +$2.35M | 0.09% | 264 |
|
|
2024
Q4 | $480M | Buy |
1,160,988
+74,324
| +7% | +$32.6M | 0.09% | 273 |
|
|
2024
Q3 | $549M | Sell |
1,086,664
-236,632
| -18% | -$115M | 0.11% | 226 |
|
|
2024
Q2 | $645M | Sell |
1,323,296
-146,815
| -10% | -$73.7M | 0.14% | 155 |
|
|
2024
Q1 | $794M | Buy |
1,470,111
+143,518
| +11% | +$78.4M | 0.17% | 121 |
|
|
2023
Q4 | $736M | Buy |
1,326,593
+109,615
| +9% | +$51.5M | 0.18% | 115 |
|
|
2023
Q3 | $532M | Sell |
1,216,978
-19,107
| -2% | -$9.53M | 0.14% | 158 |
|
|
2023
Q2 | $621M | Buy |
1,236,085
+47,256
| +4% | +$22.6M | 0.16% | 132 |
|
|
2023
Q1 | $595M | Buy |
1,188,829
+233,488
| +24% | +$112M | 0.17% | 135 |
|
|
2022
Q4 | $390M | Buy |
955,341
+76,602
| +9% | +$29.7M | 0.11% | 232 |
|
|
2022
Q3 | $286M | Buy |
878,739
+101,303
| +13% | +$37.2M | 0.09% | 297 |
|
|
2022
Q2 | $273M | Sell |
777,436
-305,143
| -28% | -$124M | 0.08% | 318 |
|
|
2022
Q1 | $592M | Buy |
1,082,579
+72,964
| +7% | +$38.4M | 0.15% | 150 |
|
|
2021
Q4 | $665M | Sell |
1,009,615
-54,544
| -5% | -$34.2M | 0.16% | 139 |
|
|
2021
Q3 | $662M | Buy |
1,064,159
+3,511
| +0.3% | +$2.36M | 0.17% | 122 |
|
|
2021
Q2 | $670M | Sell |
1,060,648
-9,034
| -0.8% | -$4.99M | 0.16% | 129 |
|
|
2021
Q1 | $523M | Buy |
1,069,682
+116,188
| +12% | +$58.2M | 0.14% | 170 |
|
|
2020
Q4 | $477M | Buy |
953,494
+228,397
| +31% | +$102M | 0.14% | 170 |
|
|
2020
Q3 | $285M | Sell |
725,097
-75,086
| -9% | -$27.8M | 0.1% | 250 |
|
|
2020
Q2 | $264M | Buy |
800,183
+186,455
| +30% | +$54M | 0.09% | 248 |
|
|
2020
Q1 | $149M | Sell |
613,728
-88,545
| -13% | -$23.1M | 0.06% | 369 |
|
|
2019
Q4 | $183M | Sell |
702,273
-869,263
| -55% | -$229M | 0.06% | 432 |
|
|
2019
Q3 | $427M | Buy |
1,571,536
+99,129
| +7% | +$27.6M | 0.11% | 199 |
|
|
2019
Q2 | $405M | Buy |
1,472,407
+323,919
| +28% | +$79.8M | 0.1% | 221 |
|
|
2019
Q1 | $257M | Buy |
1,148,488
+16,071
| +1% | +$3.32M | 0.09% | 271 |
|
|
2018
Q4 | $211M | Sell |
1,132,417
-102,611
| -8% | -$21M | 0.08% | 284 |
|
|
2018
Q3 | $308M | Buy |
1,235,028
+6,231
| +0.5% | +$1.51M | 0.1% | 224 |
|
|
2018
Q2 | $268M | Buy |
1,228,797
+401,992
| +49% | +$82.8M | 0.09% | 252 |
|
|
2018
Q1 | $158M | Sell |
826,805
-133,658
| -14% | -$24.7M | 0.06% | 333 |
|
|
2017
Q4 | $150M | Buy |
960,463
+46,484
| +5% | +$7.32M | 0.05% | 361 |
|
|
2017
Q3 | $142M | Buy |
913,979
+7,743
| +0.9% | +$1.22M | 0.05% | 375 |
|
|
2017
Q2 | $146M | Sell |
906,236
-28,350
| -3% | -$4.6M | 0.05% | 382 |
|
|
2017
Q1 | $144M | Buy |
934,586
+894,380
| +2,224% | +$123M | 0.05% | 394 |
|
|
2016
Q4 | $4.71M | Sell |
40,206
-27,248
| -40% | -$3.11M | ﹤0.01% | 2020 |
|
|
2016
Q3 | $7.61M | Buy |
67,454
+30,580
| +83% | +$3.22M | ﹤0.01% | 1681 |
|
|
2016
Q2 | $3.42M | Buy |
36,874
+1,338
| +4% | +$115K | ﹤0.01% | 2165 |
|
|
2016
Q1 | $2.78M | Sell |
35,536
-109,941
| -76% | -$7.92M | ﹤0.01% | 2258 |
|
|
2015
Q4 | $10.6M | Sell |
145,477
-8,693
| -6% | -$620K | ﹤0.01% | 1459 |
|
|
2015
Q3 | $11.4M | Sell |
154,170
-5,167
| -3% | -$370K | ﹤0.01% | 1398 |
|
|
2015
Q2 | $10.2M | Sell |
159,337
-98,555
| -38% | -$6.82M | ﹤0.01% | 1546 |
|
|
2015
Q1 | $19.9M | Sell |
257,892
-26,308
| -9% | -$2.05M | 0.01% | 1191 |
|
|
2014
Q4 | $21.1M | Buy |
284,200
+75,190
| +36% | +$5.27M | 0.01% | 1149 |
|
|
2014
Q3 | $12.3M | Sell |
209,010
-82,020
| -28% | -$5.19M | ﹤0.01% | 1427 |
|
|
2014
Q2 | $19.4M | Sell |
291,030
-12,878
| -4% | -$819K | 0.01% | 1221 |
|
|
2014
Q1 | $18.4M | Buy |
303,908
+265,036
| +682% | +$15.8M | 0.01% | 1216 |
|
|
2013
Q4 | $2.07M | Buy |
38,872
+7,632
| +24% | +$402K | ﹤0.01% | 2647 |
|
|
2013
Q3 | $1.56M | Buy |
31,240
+7,244
| +30% | +$348K | ﹤0.01% | 2725 |
|
|
2013
Q2 | $1.08M | Buy |
+23,996
| New | +$1.05M | ﹤0.01% | 2818 |
|
Other funds holding IDXX
VCM
VPM
Invesco's IDXX Position: Q1 2026 in Review
Invesco increased its Idexx Laboratories (IDXX) stake by 1.6% in Q1 2026, buying an estimated $34.3M and bringing the position to 3,349,677 shares worth $1.88B. The position accounts for 0.18% of the portfolio, ranked #90.
Invesco first reported a position in IDXX in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.23B in Q4 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.
- Invesco held 3,349,677 shares of Idexx Laboratories worth $1.88B as of Q1 2026.
- Invesco bought 53,500 Idexx Laboratories shares in Q1 2026, an estimated $34.3M.
- Idexx Laboratories made up 0.18% of Invesco's portfolio in Q1 2026, its #90 holding.
- Invesco first reported a position in Idexx Laboratories in Q2 2013 and has held it in 52 quarters since.
- Invesco's Idexx Laboratories position peaked at $2.23B in Q4 2025.
- 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.
Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.